as on September 4, 2025 at 11:38 pm IST
Day's High
3.63%
Upside
52 Week's Low
52 Week's High
59.08%
Downside
34.61%
Upside
Check Akebia Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$827.3M
EPS (TTM)
-0.03
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-7.78
Industry PE ratio
-4.14
P/B Ratio
0PEG Ratio
0EBITDA
23.3M
Revenue (TTM)
203.7M
Profit Margin
-17.91%
Return On Equity TTM
4606300.00%
Track how Akebia Therapeutics Inc P/E has moved over time to understand its valuation trends.
Akebia Therapeutics Inc in the last 5 years
Lowest (0.00x)
September 4, 2025
Today (-7.78x)
September 4, 2025
Industry (-4.14x)
September 4, 2025
Highest (-0.49x)
September 30, 2022
Today’s Price to Earnings Ratio: -7.78x
Compare market cap, revenue, PE, and other key metrics of Akebia Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $827.3M | 14.71% | -7.78 | -17.91% | |
BUY | $44.3B | NA | 21.98 | 13.81% | |
BUY | $17.7B | NA | 15.28 | 40.36% | |
BUY | $13.5B | 23.67% | 40.27 | 13.88% | |
BUY | $67.6B | NA | 26.24 | 27.83% |
The Akebia Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Akebia Therapeutics Inc investment value today
Current value as on today
₹2,21,443
Returns
₹1,21,443
(+121.44%)
Returns from Akebia Therapeutics Inc Stock
₹1,16,429 (+116.43%)
Dollar Returns*
₹5,014 (+5.01%)
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Akebia Therapeutics Inc. Average target price of $7.4
Get share price movements and forecasts by analysts on Akebia Therapeutics Inc.
What analysts predicted
59.05%UPSIDE
Target Price
$7.4
Current Price
$3.03
Analyzed by
9 Analysts
Target
$7.40
Akebia Therapeutics Inc target price $7.4, a slight upside of 59.05% compared to current price of $3.03. According to 9 analysts rating.
Search interest for Akebia Therapeutics Inc Stock has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, AKBA has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
Revenue is up for the last 4 quarters, 37.42M → 62.47M (in $), with an average increase of 15.5% per quarter
Best in 3 Years
In the last 3 years, AKBA has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
In the last 3 years, AKBA stock has moved up by 717.1%
Profit Down
Netprofit is down for the last 2 quarters, 6.11M → 247.0K (in $), with an average decrease of 96.0% per quarter
Organisation | Akebia Therapeutics Inc |
Headquarters | 245 First Street, Cambridge, MA, United States, 02142 |
Industry | Health Technology |
CEO | Mr. John P. Butler MBA |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Nicholas Grund | Senior VP & Chief Commercial Officer |
Ms. Carolyn Rucci | Senior VP of Legal, General Counsel & Secretary |
Ms. Meredith Bowman | Senior VP & Chief People Officer |
Mr. John P. Butler MBA | CEO, President & Director |
Mr. Erik John Ostrowski M.B.A. | Chief Business Officer, Senior VP, CFO & Treasurer |
Dr. Steven Keith Burke M.D. | Senior VP of Research & Development and Chief Medical Officer |
Mr. Richard C. Malabre | Chief Accounting Officer |
Ms. Kimberly Garko | Senior VP & Chief Technical Officer |
Ms. Tracey Vetterick | Vice President of Portfolio Strategy & Corporate Administration |
Mercedes Carrasco | Senior Director of Investor & Corporate Communications |
Akebia Therapeutics Inc share price today is $3.03 as on . Akebia Therapeutics Inc share today touched a day high of $3.14 and a low of $3.03.
Akebia Therapeutics Inc share touched a 52 week high of $4.08 on and a 52 week low of $1.24 on . Akebia Therapeutics Inc stock price today i.e. is trending at $3.03,which is 25.71% down from its 52 week high and 144.35% up from its 52 week low.
Akebia Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Akebia Therapeutics Inc (AKBA) shares with as little as ₹88.115 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.15 in Akebia Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Akebia Therapeutics Inc share’s latest price of $3.03 as on September 4, 2025 at 11:38 pm IST, you will get 3.3003 shares of Akebia Therapeutics Inc. Learn more about
fractional shares .
Akebia Therapeutics Inc stock has given 14.71% share price returns and 20.11% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?